Non-Invasive Neurofeedback Training to Alleviate Tinnitus Distress
Targeted Neurofeedback Training to Alleviate Tinnitus Distress
Who can join
Ages 18 to 70 · All sexes
Full eligibility criteria
Inclusion Criteria: * Non-pulsatile tinnitus for at least 6 months, * Bothersome tinnitus, based on a Tinnitus Functional Index score \> 25, * Normal cognitive processing abilities, based on a Montreal Cognitive Assessment score\> 25. Exclusion Criteria: * Clinically diagnosed dementia or Parkinson's disease, * Meniere's disease, * Severe physical or cognitive impairments that prevent completion of study tasks or scanning, * History of drug or alcohol abuse, * History of psychological or neurological illness, except for managed anxiety or depression, * Severe chronic health problems other than hearing loss or tinnitus, * Vision that is not normal or not corrected to normal, * Unable to meet MRI clinical safety screening requirements (e.g., metal in the body, pregnancy, certain implantable devices).
About the study
The broad goals of this project are to apply and validate the therapeutic utility of neurofeedback-guided intervention for tinnitus and its associated psychological sufferings. In this project, the investigators will evaluate whether targeted (non-auditory networks) neurofeedback-based training can restore emotional and cognitive health for individuals with bothersome tinnitus. The investigators will also link individual tinnitus scores with objective brain imaging measures before, during, and after the intervention. The investigators will accomplish these goals by using a combined brain imaging and behavioral experimental framework.
What is being tested
- neurofeedback-guided brain connectivity modulation (behavioral)
- sham neurofeedback-guided brain connectivity modulation (behavioral)
Sponsor: University of Illinois at Urbana-Champaign · Participants: 20 · Started: Aug 12, 2026
Contact the study team
- Fatima T Husain, PhD · Phone: 217-333-2230
Official record on ClinicalTrials.gov — NCT07788638
Locations in the U.S.
| Illinois | Beckman Institute Biomedical Imaging Centre, Urbana |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.